Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study

Introduction There are no reliable data regarding the prevalence of rheumatoid arthritis (RA) in Poland. Material and methods The first stage was a face-to-face survey on a nationwide representative sample of 3000 people, which identified respondents with a physician-confirmed diagnosis of RA. The...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bogdan Batko, Marcin Stajszczyk, Jerzy Świerkot, Karol Urbański, Filip Raciborski, Mariusz Jędrzejewski, Piotr Wiland
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2018
Materias:	rheumatoid arthritis disease activity epidemiology disease-modifying anti-rheumatic drugs Medicine R
Acceso en línea:	https://doaj.org/article/c69b933a32e34869b94e689e6feb3afb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c69b933a32e34869b94e689e6feb3afb
record_format	dspace
spelling	oai:doaj.org-article:c69b933a32e34869b94e689e6feb3afb2021-12-02T18:39:09ZPrevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study1734-19221896-915110.5114/aoms.2017.71371https://doaj.org/article/c69b933a32e34869b94e689e6feb3afb2018-12-01T00:00:00Zhttps://www.archivesofmedicalscience.com/Prevalence-and-clinical-characteristics-of-rheumatoid-arthritis-in-Poland-a-nationwide,78575,0,2.htmlhttps://doaj.org/toc/1734-1922https://doaj.org/toc/1896-9151Introduction There are no reliable data regarding the prevalence of rheumatoid arthritis (RA) in Poland. Material and methods The first stage was a face-to-face survey on a nationwide representative sample of 3000 people, which identified respondents with a physician-confirmed diagnosis of RA. The second stage was a survey of RA patients, which characterized the disease course and treatment. It was evaluated by analysis of a representative group of 1957 RA patients in routine clinical practice. Results The overall RA prevalence in Poland was 0.9% (95% CI: 0.6–1.2%), 1.06% for women, 0.74% for men. Seventy-eight percent were female, mean age was 56 and mean disease duration 7 years. Younger patients ( 5.1). Presently, low disease activity (DAS-28 < 3.2) was found in 38.5% of patients. In Poland, 94% of patients have been treated with non-steroid anti-inflammatory drugs, almost 80% with glucocorticoids. Meanwhile, methotrexate, as an anchor drug in Poland, has been used by 80% of patients, biological agents by 2.94% of patients. Conclusions This is the first cross-sectional population-based epidemiological study regarding prevalence of RA in the adult Polish population. The results demonstrate a high prevalence, falling within the upper boundary estimates for Europe. Despite ongoing treatment, the majority still have moderate to high disease activity, and the use of biological therapies is low.Bogdan BatkoMarcin StajszczykJerzy ŚwierkotKarol UrbańskiFilip RaciborskiMariusz JędrzejewskiPiotr WilandTermedia Publishing Housearticlerheumatoid arthritisdisease activityepidemiologydisease-modifying anti-rheumatic drugsMedicineRENArchives of Medical Science, Vol 15, Iss 1, Pp 134-140 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	rheumatoid arthritis disease activity epidemiology disease-modifying anti-rheumatic drugs Medicine R
spellingShingle	rheumatoid arthritis disease activity epidemiology disease-modifying anti-rheumatic drugs Medicine R Bogdan Batko Marcin Stajszczyk Jerzy Świerkot Karol Urbański Filip Raciborski Mariusz Jędrzejewski Piotr Wiland Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
description	Introduction There are no reliable data regarding the prevalence of rheumatoid arthritis (RA) in Poland. Material and methods The first stage was a face-to-face survey on a nationwide representative sample of 3000 people, which identified respondents with a physician-confirmed diagnosis of RA. The second stage was a survey of RA patients, which characterized the disease course and treatment. It was evaluated by analysis of a representative group of 1957 RA patients in routine clinical practice. Results The overall RA prevalence in Poland was 0.9% (95% CI: 0.6–1.2%), 1.06% for women, 0.74% for men. Seventy-eight percent were female, mean age was 56 and mean disease duration 7 years. Younger patients ( 5.1). Presently, low disease activity (DAS-28 < 3.2) was found in 38.5% of patients. In Poland, 94% of patients have been treated with non-steroid anti-inflammatory drugs, almost 80% with glucocorticoids. Meanwhile, methotrexate, as an anchor drug in Poland, has been used by 80% of patients, biological agents by 2.94% of patients. Conclusions This is the first cross-sectional population-based epidemiological study regarding prevalence of RA in the adult Polish population. The results demonstrate a high prevalence, falling within the upper boundary estimates for Europe. Despite ongoing treatment, the majority still have moderate to high disease activity, and the use of biological therapies is low.
format	article
author	Bogdan Batko Marcin Stajszczyk Jerzy Świerkot Karol Urbański Filip Raciborski Mariusz Jędrzejewski Piotr Wiland
author_facet	Bogdan Batko Marcin Stajszczyk Jerzy Świerkot Karol Urbański Filip Raciborski Mariusz Jędrzejewski Piotr Wiland
author_sort	Bogdan Batko
title	Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
title_short	Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
title_full	Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
title_fullStr	Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
title_full_unstemmed	Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
title_sort	prevalence and clinical characteristics of rheumatoid arthritis in poland: a nationwide study
publisher	Termedia Publishing House
publishDate	2018
url	https://doaj.org/article/c69b933a32e34869b94e689e6feb3afb
work_keys_str_mv	AT bogdanbatko prevalenceandclinicalcharacteristicsofrheumatoidarthritisinpolandanationwidestudy AT marcinstajszczyk prevalenceandclinicalcharacteristicsofrheumatoidarthritisinpolandanationwidestudy AT jerzyswierkot prevalenceandclinicalcharacteristicsofrheumatoidarthritisinpolandanationwidestudy AT karolurbanski prevalenceandclinicalcharacteristicsofrheumatoidarthritisinpolandanationwidestudy AT filipraciborski prevalenceandclinicalcharacteristicsofrheumatoidarthritisinpolandanationwidestudy AT mariuszjedrzejewski prevalenceandclinicalcharacteristicsofrheumatoidarthritisinpolandanationwidestudy AT piotrwiland prevalenceandclinicalcharacteristicsofrheumatoidarthritisinpolandanationwidestudy
_version_	1718377766239338496

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study

Ejemplares similares